Li Xiang Yu - Net Worth and Insider Trading
Li Xiang Yu Net Worth
The estimated net worth of Li Xiang Yu is at least $5 Million dollars as of 2025-07-07. Li Xiang Yu is the senior management of Cabio Biotech (Wuhan) Co Ltd and owns about 202,871 shares of Cabio Biotech (Wuhan) Co Ltd (SHSE:688089) stock worth over $5 Million. Details can be seen in Li Xiang Yu's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Li Xiang Yu has not made any transactions after 2023-11-24 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Li Xiang Yu
Li Xiang Yu Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Li Xiang Yu owns 1 companies in total, including Cabio Biotech (Wuhan) Co Ltd (SHSE:688089) .
Click here to see the complete history of Li Xiang Yu’s form 4 insider trades.
Insider Ownership Summary of Li Xiang Yu
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| SHSE:688089 | Cabio Biotech (Wuhan) Co Ltd | 2023-11-24 | senior management |
Li Xiang Yu Latest Holdings Summary
Li Xiang Yu currently owns a total of 1 stock. Li Xiang Yu owns 202,871 shares of Cabio Biotech (Wuhan) Co Ltd (SHSE:688089) as of November 24, 2023, with a value of $5 Million.
Latest Holdings of Li Xiang Yu
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SHSE:688089 | Cabio Biotech (Wuhan) Co Ltd | 2023-11-24 | 202,871 | 25.03 | 5,077,861 |
Holding Weightings of Li Xiang Yu
Li Xiang Yu Form 4 Trading Tracker
According to the SEC Form 4 filings, Li Xiang Yu has made a total of 5 transactions in Cabio Biotech (Wuhan) Co Ltd (SHSE:688089) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in Cabio Biotech (Wuhan) Co Ltd is the acquisition of 10,000 shares on November 24, 2023, which cost Li Xiang Yu around $194,100.
Insider Trading History of Li Xiang Yu
- 1
Li Xiang Yu Trading Performance
GuruFocus tracks the stock performance after each of Li Xiang Yu's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Li Xiang Yu is -19.88%. GuruFocus also compares Li Xiang Yu's trading performance to market benchmark return within the same time period. The performance of stocks bought by Li Xiang Yu within 3 months outperforms 0 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Li Xiang Yu's insider trading performs compared to the benchmark.
Performance of Li Xiang Yu
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -2.41 | | | | | |
| Relative Return to S&P 500(%) | -5.35 | | | | | |
Li Xiang Yu Ownership Network
Ownership Network List of Li Xiang Yu
Ownership Network Relation of Li Xiang Yu
Li Xiang Yu Owned Company Details
What does Cabio Biotech (Wuhan) Co Ltd do?
Who are the key executives at Cabio Biotech (Wuhan) Co Ltd?
Li Xiang Yu is the senior management of Cabio Biotech (Wuhan) Co Ltd. Other key executives at Cabio Biotech (Wuhan) Co Ltd include Core technical personnel Shang Yun , senior management Xiao Min , and Directors & senior managers Wang Hua Biao .
Cabio Biotech (Wuhan) Co Ltd (SHSE:688089) Insider Trades Summary
Over the past 18 months, Li Xiang Yu made no insider transaction in Cabio Biotech (Wuhan) Co Ltd (SHSE:688089). Other recent insider transactions involving Cabio Biotech (Wuhan) Co Ltd (SHSE:688089) include a net purchase of 37,000 shares made by Ma Tao , a net sale of 25,800 shares made by Xiao Min , and a net purchase of 23,000 shares made by Du Bin .
In summary, during the past 3 months, insiders sold 0 shares of Cabio Biotech (Wuhan) Co Ltd (SHSE:688089) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 31,800 shares of Cabio Biotech (Wuhan) Co Ltd (SHSE:688089) were sold and 95,136 shares were bought by its insiders, resulting in a net purchase of 63,336 shares.
Cabio Biotech (Wuhan) Co Ltd (SHSE:688089)'s detailed insider trading history can be found in Insider Trading Tracker table.
Cabio Biotech (Wuhan) Co Ltd Insider Transactions
Li Xiang Yu Mailing Address
Above is the net worth, insider trading, and ownership report for Li Xiang Yu. Currently GuruFocus does not have mailing address information for Li Xiang Yu.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
